Gaspar J, Vonderwalde C, Hong MK, Eid-Lidt G, Almagor Y, León MB

Language: Spanish
References: 29
Page: 286-294
PDF size: 329.99 Kb.

ABSTRACT

Covering a stent with a membrane (stent graft) allows treatment of diverse coronary abnormalities such as aneurysms, rupture and fistulas (which, until recently, required surgical therapy). A stent graft could also reduce embolic complications associated with angioplasty of saphenous vein grafts. The objective of this study is to evaluate bovine pericardium as a graft for conventional stents. In vitro testing of the bovine pericardium disclosed an elasticity of 15% and a resistance to rupture of 0.22 kg/mm², well above the pressure commonly used during stent deployment. In 18 pigs, 29 of 32 (90.63%) attempts to implant stent grafts were successful. Hystology of acute porcine studies revealed correct apposition of the stent graft to the vessel wall, subacute and chronic (10 days and 1 month) samples showed adequate endothelization and exclusion of proliferative media. Twenty stents were placed in 15 patients with a 100% success rate. Seven patients had coronary aneurysms and in all a complete exclusion of the aneurysm was obtained without complications. Fourteen patients have a follow-up of 6 or more months with evidence of clinical restenosis in 2 (14.28%), whereas angiographic follow-up in 9 patients, which included the 2 cases with recurrent angina, evidenced restenosis in 3 of 14 stents (21.4%), two of which were overlapped in the LAD of one patient and one corresponded to a series of 9 stents (in 5 patients) placed in saphenous vein grafts. It is concluded that bovine pericardium is a suitable material for stent-grafts and its efficacy to seal coronary aneurysms was demonstrated. These results warrant a larger comparative study to better define its restenosis rate and further delineate its usefulness in the treatment of diseased saphenous vein grafts.

REFERENCES

1. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, et al: Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-27.

2. Altman DB, Racz M, Battleman DS, Bergman G, Spokojny A, Hannan EL, et al: Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. Am Heart J 1996; 132: 503-507.

3. Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, et al: Continued benefit of coronary stenting versus balloon angioplasty: one year clinical follow-up of Benestent trial. J Am Coll Cardiol 1996; 27: 255-61.

4. De Feyter PJ, Van Sylen RJ, De Jaegere PPT, Topol EJ, Serruys PW: Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993; 21: 1539-49.

5. Shah MS, Raymond RE: Coronary perforations: a persistent problem in interventions [Abstract]. J Am Coll Cardiol 1998; 31(suppl): 493A.

6. Syed M, Lesch M: Coronary artery aneurysm: a review. Prog Cardiovasc Dis 1997; 40: 77-84.

7. Stefanadis C, Toutouzas P: Percutaneous implantation of autologous vein graft stent for the treatment of coronary artery disease. Lancet 1995; 345: 1509.

8. 8. Wong SC, Kent KM, Mintz GS, Pichard AD, Satler LF, García J, et al: Percutaneous transcatheter repair of a coronary aneurysm using a composite autologous cephalic vein-coated Palmaz-Schatz biliary stent. Am J Cardiol 1995; 76: 990-1.

9. Gruberg L, Roguin A, Beyar R: Percutaneous closure of a coronary aneurysm with a vein-coated stent. Cathet Cardiovasc Diagn 1998; 43: 308-10.

10. Gaspar J, Vonderwalde C, Eid-Lidt G: Treatment of coronary artery aneurysms by percutaneous sealing with bovine-pericardium-covered stents. Int J Cardiovasc Intervent 1999; 2: 241-246.

11. Sigwart U: Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 211-214.

12. Braunwald E: Induced septal infarction: a new therapeutic strategy for hypertrophic obstructive cardiomyopathy. Circulation 1997; 95: 1981-1982.

13. Fannapazir L, McAreavey D: Therapeutic options in patients with obstructive hypertrophic cardio-myopathy and severe drug-refractory symptoms. J Am Coll Cardiol 1998; 31: 259-264.

14. Knight C, Kurbaan AS, Segewiss H, Henein M, Gunning M, Harrington D, et al: Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997; 95: 2075-2081.

15. Gaspar J, Martínez-Ríos MA, Vonderwalde C, Rosas M, Ban E, Eidt-Lidt G, et al: Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Cathet Cardiovasc Intervent 1999; 47: 73-79.

16. Gaspar J: Reply to the letter to the Editor by Seggewiss. Cathet Cardiovasc Intervent 1999; 48: 242.

17. Wright WP, Alpert MA, Mukerji V, Santolin CJ: Coronary artery aneurysms-A case study and literature review. Angiology 1991; 42: 672-679.

18. Demopoulos VP, Olympios CD, Fakiolas CN, Pissimissis EG, Economides NM, Adamopolou E, et al: The natural history of aneurysmal coronary artery disease. Heart 1997; 78: 136-41.

19. Etheridge SP, Tani LY, Minich LL, Revenaugh JR: Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease. Cathet Cardiovasc Diagn 1998; 45: 264-8.

20. De Jaegere PP, Van Domburg RT, De Feyter PJ, Ruygrok PN, van der Giessen WJ, van den Brand MJ, et al: Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996; 28: 89-96.

21. Hong MK, Mehran R, Dangas, Mintz GS, Lansky AJ, Pichard AD, et al: Enzyme elevation following successful saphenous vein graft interventions is associated with late mortality. Circulation 1999; 100: 2400-2405.

22. Goldberg SL, DiMario C, Hall P, Colombo A: Comparison of aggressive versus nonaggressive balloon dilatation for stent deployment on late loss and reestenosis in coronary arteries. Am J Cardiol 1998; 81: 708-712.

23. Hong MK, Mehran R, Mintz GA, Leon B: Reestenosis after coronary angioplasty. Curr Problems Cardiol 1997; 22: 1-36.

24. Rodríguez A, Santaera O, Larribau OM, Fernández M, Sarmiento R, Pérez-Baliño N, et al: Coronary stenting decrease restenosis in lesions with early loss in lumen diameter 24 hours after successful PTCA. Circulation 1995; 91: 1397-1402.

25. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, et al: Patterns and mechanism of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.

26. Kasaoka S, Tobis JM, Akiyama T, Reimers B, Di Mario C, Wong ND, et al: Angiographic and intravascular ultrasound predictors of in-stent reestenosis. J Am Coll Cardiol 1998; 32: 1630-1635.

27. Haager PK, Schwarz ER, von Dahl J, Klues HG, Reffelmann T, Hanrath P: Long-term angiographic and clinical follow-up in patients whit stent implantation for symptomatic myocardial bridging. Heart 2000; 84: 403-408.

28. Tscuchida H, Wilson SE, Ishimara S: Healing mechanisms of high-porosity PTFE grafts: significance of transmural structure. J Surg Res 1997; 71: 187-195.

29. Campbell PG, Hall JA, Harcombe AA, de Belder MA: The Jomed covered stent graft for coronary artery aneurysms and acute perforation: a successful device which needs careful deployment and may not reduce restenosis. J Invas Cardiol 2000; 12: 272-276.